Interest Rates In Australia Are Raised To A 12-Year High Australia’s central bank raised interest rates to a 12-year high in another attempt to contain inflationary pressures in an economy fueled by China’s hunger for resources.... Read Full Article Game Theory: Surgery On A Plane: Lightning-Sharp Reflexes Needed In Trauma Center: Second Opinion, which falls somewhere between a medical simulation and an arcade game, surgeons must slice and suture with blinding speed.... Read Full Article U.N. Panel Urges Changes To Feed Poor While Saving Environment The price of basic food like rice, wheat and corn has been rising sharply, setting off violent protests in Haiti, Egypt, Uzbekistan, Yemen, the Philippines, Thailand, Indonesia and even Italy.... Read Full Article Drug Maker And Eye Doctors Settle Dispute Over Avastin Genentech appears to have resolved a dispute with ophthalmologists over use of the company’s drug Avastin to treat eye diseases.... Read Full Article Bayer Drops Drug From A Cancer Trial A late-stage trial of Nexavar in patients with nonsmall-cell lung cancer after a committee said it would not meet the main goal of improving overall survival.... Read Full Article |
World Business Briefing: India: Profit Doubles At Drug MakerThe Indian pharmaceutical company Ranbaxy Laboratories said its profit in the latest quarter more than doubled from a year ago, helped by robust sales in Europe and huge gains in foreign exchange transactions. Net profit at Ranbaxy rose to 2.66 billion rupees ($65 million), from 1.22 billion rupees ($29 million) in the quarter a year earlier. The growth rate, however, drops to 53 percent if the earnings numbers are adjusted against about 1 billion rupees in net gains the company made from foreign exchange transactions, said Malvinder Singh, the chief executive. More than half of Ranbaxys sales come from overseas markets other than the United States. Sales rose 12.3 percent, to 16.24 billion rupees ($395 million). Tag CloudExternal InformationAdditional InformationT-Mobile Offers 3G in New York...Westpac and ANZ borrowers to feel rate sting... Market Place: Citigroup Has a C.F.O. Now What?... Slipstream: Awaiting the Day When Everyone Writes Software... Where Am I?News Main Page - Business - World Business Briefing: India: Profit Doubles At Drug Maker |
i8news.com |